2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: 406-413. PMID: 27598807, PMCID: PMC5575932, DOI: 10.1016/j.ijrobp.2016.06.006.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAgedAged, 80 and overAnaplastic Lymphoma KinaseAntineoplastic AgentsBrain NeoplasmsErbB ReceptorsFemaleGenetic MarkersGenetic Predisposition to DiseaseHumansIncidenceLung NeoplasmsMaleMiddle AgedMutationPolymorphism, Single NucleotidePrevalenceProtein-Tyrosine KinasesReceptor Protein-Tyrosine KinasesRetrospective StudiesRisk FactorsSurvival RateUnited StatesConceptsTyrosine kinase inhibitionBrain metastasesMedian survivalCause of deathGene alterationsDiagnosis of BMMulti-institutional retrospective databaseTKI-naïve patientsRisk of deathLonger median survivalKinase inhibitionALK gene alterationsTreatment patternsCancer mortalityLung cancerPrimary diagnosisRetrospective databaseCommon causeLung adenocarcinomaGroup overallPatientsFirst treatmentPrior trialsEGFRMonthsPredicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics.
Taylor BF, Knisely JP, Qian JM, Yu JB, Chiang VL. Predicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics. Journal Of Radiosurgery And SBRT 2016, 4: 53-60. PMID: 29296426, PMCID: PMC5658837.Peer-Reviewed Original ResearchTreatment-related imaging changesPrescription isodose volumeConformity indexStereotactic radiosurgeryTumor volumeGamma Knife stereotactic radiosurgeryRadiation dose volumeSmall-volume lesionsPaddick conformity indexPost-treatment periodBrain metastasesAdditional patientsImaging changesDifferent post-treatment periodsTransient enlargementTreatment doseIsodose volumeRadiographic lesionsVolume lesionsClinical decisionDose volumeMetastasisTreatment factorsMonthsMonth period
2014
BM-10SYSTEMIC TREATMENT AND RADIATION NECROSIS FOLLOWING GKSRS IN THE TREATMENT OF BRAIN METASTASES
Colaco R, Martin P, Bond J, Bindra R, Contessa J, Kluger H, Yu J, Chiang V. BM-10SYSTEMIC TREATMENT AND RADIATION NECROSIS FOLLOWING GKSRS IN THE TREATMENT OF BRAIN METASTASES. Neuro-Oncology 2014, 16: v34-v34. PMCID: PMC4217910, DOI: 10.1093/neuonc/nou240.10.Peer-Reviewed Original Research
2011
Implications of Identifying Additional Cerebral Metastases during Gamma Knife Radiosurgery
Patel TR, Ozturk AK, Knisely JP, Chiang VL. Implications of Identifying Additional Cerebral Metastases during Gamma Knife Radiosurgery. International Journal Of Surgical Oncology 2011, 2012: 748284. PMID: 22312543, PMCID: PMC3265271, DOI: 10.1155/2012/748284.Peer-Reviewed Original ResearchMagnetic resonance imagingNumber of metastasesAdditional metastasesGamma knife radiosurgeryGK-SRSCerebral metastasesAdditional lesionsKnife radiosurgeryProgressive systemic diseaseTreatment magnetic resonance imagingKaplan-Meier analysisImportant prognostic informationMedian survivalRetrospective reviewIntracranial metastasesSystemic diseasePrognostic informationMetastasisPatientsResonance imagingLesionsRadiosurgeryMonthsDaysDisease